Neuromodulation of cortical circuits in health and disease
健康和疾病中皮质回路的神经调节
基本信息
- 批准号:8576665
- 负责人:
- 金额:$ 40.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-08-16 至 2018-07-31
- 项目状态:已结题
- 来源:
- 关键词:AdultAgonistAmygdaloid structureAnimalsAnxietyBehaviorBehavioralBrainCerebral cortexCerebrumClinicalCognitionCognitiveCoupledDataDiseaseExtinction (Psychology)FrightFunctional disorderGlutamatesGoalsHTR2A geneHealthHumanKnowledgeLabelLaboratory FindingMedialMediatingMental DepressionMental disordersMinorityMissionMusNational Institute of Mental HealthNeocortexNeuronsNeurotransmittersOutputPerformancePhysiologicalPopulationPrefrontal CortexProcessPublic HealthResearchRoleSchizophreniaSerotoninSerotonin AgentsSignal TransductionStructureSynapsesSynaptic TransmissionTestingTracerVariantatypical antipsychoticbaseclinically significantcognitive functionconditioned fearconditioningdensityexecutive functiongamma-Aminobutyric Acidhippocampal pyramidal neuronhuman CCXCR1 receptorin vivoinformation processinginnovationinsightmouse modelneuroregulationoptogeneticspostsynapticpublic health relevancereceptorresponseselective expressiontool
项目摘要
DESCRIPTION (provided by applicant): Cortical microcircuits, comprising specialized neuron subpopulations and their selective synaptic connections, form functionally segregated output channels to other cortical and subcortical targets. The activity of cortical microcircuits is regulated by a number of "modulatory" neurotransmitters, such as serotonin (5-HT), that optimize circuit performance for specific cognitive tasks, and which are implicated in a wide spectrum of mental health disorders. For instance, disrupted 5-HT signaling contributes to schizophrenia, depression, and anxiety, while serotonergic drugs are widely used to treat these disorders. However, despite their functional and clinical importance, little is known about how modulatory transmitters selectively regulate the activity of cortical neuron subpopulations subserving specific functional roles within cortical microcircuits. Our long-term goal is to characterize the functional impact of modulatory neurotransmitters on cortical microcircuit function. The research proposed here represents an important first step toward this goal by identifying key cellular and synaptic components of cortical microcircuits differentially regulated
by 5-HT. Serotonergic signaling in excitatory cortical neurons relies primarily on two G-protein coupled receptors, 5-HT1A (1A) and 5-HT2A (2A), that have opposing influences on neuron excitability. Based on recent results showing commissural/callosal (COM) projection neurons are selectively excited by 5-HT, our central hypothesis is that endogenous 5-HT acts to selectively enhance the activity of neurons participating in specific executive functions, while suppressing the bulk of cortical output to subcortical structures. Our first aim is to identify the
cellular components of cortical circuits that are functionally excited or inhibited by endogenous 5-HT. This will be accomplished in a mouse model in which channelrhodopsin-2 is selectively expressed in 5-HT neurons, and using fluorescent retrograde tracers delivered in vivo. Our second aim is to characterize synaptic connectivity among populations of 5-HT-excited neurons to determine whether they form networks capable of the sustained activity associated with executive functions. Finally, our third aim will confirm in behaving animals preferential activatio of COM or other 5-HT-excited neuron populations by 2A agonists, fear conditioning, and extinction of conditioned fear. These aims are innovative in combining anatomical, physiological, optogenetic, and behavioral approaches to characterize selective modulation of cellular components and synaptic connections underlying functionally defined cortical output channels. The results will be significant in providing a framework for understanding the functional role of 5
HT in regulating the output of cortical circuits. The new knowledge gained will provide insight into how 5-HT facilitates normal cognition and behavior, and why dysregulation of serotonergic signaling in the cerebral cortex leads to the behavioral deficits observed in schizophrenia, depression, and other mental health disorders.
描述(由申请人提供):皮层微电路,包括专门的神经元亚群和它们的选择性突触连接,形成功能隔离的输出通道到其他皮层和皮层下目标。皮层微回路的活动受到许多“调节性”神经递质的调节,如血清素(5-HT),它可以优化特定认知任务的回路性能,并与广泛的精神健康障碍有关。例如,5-羟色胺信号被破坏会导致精神分裂症、抑郁症和焦虑症,而5-羟色胺能药物被广泛用于治疗这些疾病。然而,尽管它们具有功能和临床重要性,但对于调节递质如何选择性地调节皮层微回路中服务于特定功能角色的皮层神经元亚群的活动知之甚少。我们的长期目标是表征调节性神经递质对皮质微回路功能的功能影响。这里提出的研究通过识别皮层微回路差异调节的关键细胞和突触成分,代表了实现这一目标的重要的第一步
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Allan T Gulledge其他文献
Allan T Gulledge的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Allan T Gulledge', 18)}}的其他基金
Coordinated modulation of cortical circuits by serotonin and acetylcholine
血清素和乙酰胆碱对皮质回路的协调调节
- 批准号:
10665047 - 财政年份:2021
- 资助金额:
$ 40.5万 - 项目类别:
Cortical circuitry and mechanisms underlying remote cue-specific fear memory and extinction
远程线索特异性恐惧记忆和消退背后的皮层电路和机制
- 批准号:
10612415 - 财政年份:2019
- 资助金额:
$ 40.5万 - 项目类别:
Cortical circuitry and mechanisms underlying remote cue-specific fear memory and extinction
远程线索特异性恐惧记忆和消退背后的皮层电路和机制
- 批准号:
10401949 - 财政年份:2019
- 资助金额:
$ 40.5万 - 项目类别:
Cortical circuitry and mechanisms underlying remote cue-specific fear memory and extinction
远程线索特异性恐惧记忆和消退背后的皮层电路和机制
- 批准号:
9815038 - 财政年份:2019
- 资助金额:
$ 40.5万 - 项目类别:
Cortical circuitry and mechanisms underlying remote cue-specific fear memory and extinction
远程线索特异性恐惧记忆和消退背后的皮层电路和机制
- 批准号:
10417350 - 财政年份:2019
- 资助金额:
$ 40.5万 - 项目类别:
Neuromodulation of cortical circuits in health and disease
健康和疾病中皮质回路的神经调节
- 批准号:
8722034 - 财政年份:2013
- 资助金额:
$ 40.5万 - 项目类别:
Cholinergic signaling in cortical neurons: a unifying hypothesis
皮质神经元中的胆碱能信号传导:一个统一的假设
- 批准号:
7888378 - 财政年份:2008
- 资助金额:
$ 40.5万 - 项目类别:
Cholinergic signaling in cortical neurons: a unifying hypothesis
皮质神经元中的胆碱能信号传导:一个统一的假设
- 批准号:
7655524 - 财政年份:2008
- 资助金额:
$ 40.5万 - 项目类别:
Cholinergic signaling in cortical neurons: a unifying hypothesis
皮质神经元中的胆碱能信号传导:一个统一的假设
- 批准号:
8089261 - 财政年份:2008
- 资助金额:
$ 40.5万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 40.5万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 40.5万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 40.5万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 40.5万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 40.5万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 40.5万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 40.5万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 40.5万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 40.5万 - 项目类别:
Fentanyl Addiction: Individual Differences, Neural Circuitry, and Treatment with a GLP-1 Receptor Agonist
芬太尼成瘾:个体差异、神经回路和 GLP-1 受体激动剂治疗
- 批准号:
10534864 - 财政年份:2023
- 资助金额:
$ 40.5万 - 项目类别:














{{item.name}}会员




